Sandra M. Swain

Hackensack Meridian Health and Georgetown Lombardi Comprehensive Cancer Center Become Associate Members of the New York Genome Center

Retrieved on: 
Thursday, December 19, 2019
Georgetown University Medical Center, Health, NCI-designated Cancer Center, Georgetown Lombardi Comprehensive Cancer Center, National Cancer Institute, Lombardi, Roswell Park Comprehensive Cancer Center, Georgetown University, Association of American Cancer Institutes, Sandra M. Swain

NEW YORK, Dec. 19, 2019 /PRNewswire/ --The New York Genome Center (NYGC) announced today that Hackensack Meridian Health and the Georgetown Lombardi Comprehensive Cancer Center have become the two newest institutional associate members of the NYGC.

Key Points: 
  • NEW YORK, Dec. 19, 2019 /PRNewswire/ --The New York Genome Center (NYGC) announced today that Hackensack Meridian Health and the Georgetown Lombardi Comprehensive Cancer Center have become the two newest institutional associate members of the NYGC.
  • Georgetown Lombardi Comprehensive Cancer Center is Washington, D.C.'s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center and NCI-approved consortium.
  • The second partnership is focused on cancer genomics and led by Georgetown Lombardi Comprehensive Cancer Center, which includes investigators from Georgetown University Medical Center, along with the Hackensack Meridian Health's John Theurer Cancer Center and CDI.
  • Institutional associate members are: American Museum of Natural History, Georgetown Lombardi Comprehensive Cancer Center, Hackensack Meridian Health, Hospital for Special Surgery, The New York Stem Cell Foundation, Princeton University, and Roswell Park Cancer Institute.

OncLive® Presents State of the Science Summit™ on Breast Cancer

Retrieved on: 
Tuesday, September 3, 2019
Other Health, Oncology, General Health, Women, Hospitals, Science, Biotechnology, Consumer, Nursing, Research, Health, Medicine, Clinical medicine, Health, RTT, Breast cancer, HER2/neu, Triple-negative breast cancer, Eric Winer, Sandra M. Swain

The summit will be chaired by P. Kelly Marcom, M.D., oncologist, professor in the department of medicine at Duke Cancer Institute.

Key Points: 
  • The summit will be chaired by P. Kelly Marcom, M.D., oncologist, professor in the department of medicine at Duke Cancer Institute.
  • This interactive and educational meeting will explore the variety of novel treatment approaches for patients with breast cancer.
  • Expert presenters will discuss topics facing breast cancer specialists, oncologists, nurses and other medical professionals, such as management of hormone receptive-positive/HER2-negative early stage disease, updates in metastatic hormone receptor-positive/HER2-negative disease, cardio-oncology in breast cancer, managing brain metastases in breast cancer, and HER2-positive breast cancer and triple-negative breast cancer.
  • Presenters for the summit will include the following experts from the Duke Cancer Institute:
    State of the Science Summit is a premier conference series, hosted by OncLive, that features medical experts from across the nation discussing treatment options.